AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
MED vs AAPL Fundamental Comparison
| Metric | MED | AAPL |
|---|---|---|
| Revenue | $385.8M | $143.8B |
| Net Income | $-18.7M | $42.1B |
| Net Margin | -4.8% | 29.3% |
| ROE | -9.4% | 47.7% |
| ROA | -7.5% | 11.1% |
| Current Ratio | 4.69x | 0.97x |
| Debt/Equity | 0.00x | 1.00x |
| EPS | $-1.70 | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MED vs AAPL: Frequently Asked Questions
Is MED or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. MED is rated SELL (85% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does MED compare to AAPL fundamentally?
MEDIFAST INC has ROE of -9.4% vs Apple Inc.'s 47.7%. Net margins are -4.8% vs 29.3% respectively.
Which stock pays higher dividends, MED or AAPL?
MED has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MED or AAPL for long term?
For long-term investing, consider that MED has SELL rating with 85% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MED vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MED vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.